"UChicago Medicine Duchossois Center for Advanced Medicine - Hyde Park, also known as DCAM, is our flagship outpatient facility. Located in Chicago's historic Hyde Park neighborhood, this six-story building puts comprehensive diagnostic care and world-class treatment under one roof. Home to dozens of primary and specialty clinics as well as a pharmacy, the building includes more than 300 exam rooms, nearly 100 procedure rooms, surgery suites and imaging equipment including PET/CT and MRI scanners. It also has facilities for nuclear medicine along with linear accelerators and simulators for radiation therapy."

During the past decade, Duchossois Center for Advanced Medicine conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 4 clinical trials were completed, i.e. on average, 57.1% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 3 clinical trials were completed. i.e. 150% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Duchossois Center for Advanced Medicine" #1 sponsor was "Cytokinetics" with 2 trials, followed by "Hoffmann-La Roche" with 2 trials sponsored, "University of Chicago" with 2 trials sponsored, "EP MedSystems" with 1 trials sponsored and "MedDay Pharmaceuticals SA" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Duchossois Center for Advanced Medicine" #1 collaborator was "Astellas Pharma Inc" with 1 trials as a collaborator, "Myovant Sciences GmbH" with 1 trials as a collaborator and "Northwestern University" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Duchossois Center for Advanced Medicine" are "Amyotrophic Lateral Sclerosis" (2 trials), "Atrial Fibrillation" (1 trials), "Autism Spectrum Disorder" (1 trials), "Breast Cancer" (1 trials) and "Colon Cancer" (1 trials). Many other conditions were trialed in "Duchossois Center for Advanced Medicine" in a lesser frequency.

Most popular intervention types in "Duchossois Center for Advanced Medicine" are "Drug" (9 trials), "Biological" (1 trials), "Device" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Reldesemtiv" (2 trials), "Balovaptan" (1 trials), "Bitopertin" (1 trials) and "Capecitabine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Duchossois Center for Advanced Medicine" are 10 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Duchossois Center for Advanced Medicine". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Duchossois Center for Advanced Medicine, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Duchossois Center for Advanced Medicine, 2 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".